title: [The therapeutic correction of disorders in thrombocyte-vascular hemostasis and of changes in the rheological properties of the blood in patients with arterial hypertension].
abstract: 158 patients with essential hypertension received beta-adrenoblockers and were exposed to travelling impulse magnetic field, magnetolaser radiation. The study of platelet-vessel hemostasis and blood rheology revealed a relation of good clinical response and increased exercise tolerance with initial platelet dysfunction and rheological disorders which underwent positive changes in the course of treatment.
authors.forename: V S
authors.initials: VS
authors.lastname: Zadionchenko
authors.forename: K M
authors.initials: KM
authors.lastname: Bagatyrova
authors.forename: T V
authors.initials: TV
authors.lastname: Adasheva
authors.forename: N Iu
authors.initials: NIu
authors.lastname: Timofeeva
authors.forename: T P
authors.initials: TP
authors.lastname: Zaporozhets
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage; D000328:Adult; D000368:Aged; D000959:Antihypertensive Agents / Q000008:administration & dosage; D001262:Atenolol / Q000008:administration & dosage; D001791:Blood Platelet Disorders / Q000097:blood / Q000209:etiology / Q000503:physiopathology / Q000628:therapy*; D003131:Combined Modality Therapy; D005260:Female; D018056:Hemorheology / Q000187:drug effects / Q000528:radiation effects; D006487:Hemostasis / Q000187:drug effects / Q000528:radiation effects; D006801:Humans; D006973:Hypertension / Q000097:blood / Q000209:etiology / Q000503:physiopathology / Q000628:therapy*; D007259:Infrared Rays / Q000627:therapeutic use; D053685:Laser Therapy; D008280:Magnetics / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged
chemical_list: D000319:Adrenergic beta-Antagonists; D000959:Antihypertensive Agents; D001262:Atenolol
vernacular_title: Lechebnaia korrektsiia narusheniĭ trombotsitarno-sosudistogo gemostaza i izmeneniĭ reologicheskikh svoĭstv krovi u bol'nykh arterial'noĭ gipertonieĭ.